Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy

By Grant R.   Shorvon S.D.  

Epilepsy Research, Vol. 42, Iss. 2, 2000-12 ,pp. : 89-95

Elsevier

Access to resources Recommend Favorite

Clinical efficacy of gabapentin as add-on therapy for resistant partial epilepsy

By Tomovic M.   Ilic T.   Dincic E.   Jovicic A.  

Electroencephalography and Clinical Neurophysiology, Vol. 103, Iss. 1, 1997-07 ,pp. : 135-136

Elsevier

Access to resources Recommend Favorite

The efficacy of felbamate as add-on therapy to valproic acid in the Lennox-Gastaut syndrome

By Siegel H.   Kelley K.   Stertz B.   Reeves-Tyer P.   Flamini R.   Malow B.   Gaillard W.D.   Ko D.   Theodore W.H.  

Epilepsy Research, Vol. 34, Iss. 2, 1999-04 ,pp. : 91-97

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs

By Peduzzi P.   Concato J.   Feinstein A.R.   Holford T.R.   So E.L.   Wolff D.   Graves N.M.   Leppik I.E.   Cascino G.D.   Pixton G.C.   Gustavson L.E.  

Epilepsy Research, Vol. 22, Iss. 3, 1995-11 ,pp. : 221-226

Elsevier

Access to resources Recommend Favorite

Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial

By Coppola G.   Capovilla G.   Montagnini A.   Romeo A.   Spano M.   Tortorella G.   Veggiotti P.   Viri M.   Pascotto A.  

Epilepsy Research, Vol. 49, Iss. 1, 2002-03 ,pp. : 45-48

Elsevier

Access to resources Recommend Favorite